Gene Editing Market Size By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), By Technology (CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), TALENs), By End-user (Biotech and Pharma Companies, Contract Research Organizations (CROs), Research Institutes), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Sep 2020  |  Report ID: GMI810  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 141   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Industry trends

Gene Editing Market size valued at USD 3.8 billion in 2019 and is expected to witness 14.9% CAGR from 2020 to 2026. Increasing advancements in gene editing technologies are anticipated to boost the market demand.
 

Growing awareness regarding availability of genetically modified crops and animals will have positive impact on the overall market revenue. Growing utilization of synthetic genes in incorporating newer biosynthetic pathway in microorganisms to manufacture biologics will escalate the market growth.
 

Gene Editing Market
Get more details on this report - Request Free Sample PDF
 

Scientific communities are considering gene editing tools such as CRISPR to potentially disrupt the SARS-CoV-2 genome, the virus that causes COVID-19. This is anticipated to create growth opportunities for the businesses to invest in the gene editing market. In June 2020, Stanford University developed gene editing tool that destroys COVID-19 inside human cells. The tool is called PAC-MAN (Prophylactic Antiviral CRISPR in human cells). Development of such new and innovative gene editing approaches will fuel the market expansion.
 

Increased funding for genetic research in developed regions including North America will propel the gene editing industry growth. The U.S. government funds various research programs that facilitates the process of drug discovery for several rare genetic diseases. The National Institutes of Health (NIH), a primary agency of the U.S. government is responsible for research in biomedical and genetics and grants billions of dollars in funding. Research activities for drug discovery increase the preference for gene editing techniques. Also, recently developed therapies and drugs used in treatment of genetic diseases have reduced the mortality rates that will positively influence the industry size.
 

Gene Editing Market Report Coverage
Report Coverage Details
Base Year: 2019 Market Size in 2019: 3.8 Billion (USD)
Historical Data for: 2015 to 2019 Forecast Period: 2020 to 2026
Forecast Period 2020 to 2026 CAGR: 14.9% 2026 Value Projection: 10.0 Billion (USD)
Pages: 141 Tables, Charts & Figures: 117
Geographies covered (20): U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Poland, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE
Segments covered: Application, Technology, End-user and Region
Companies covered (22): Addgene, Inc., Agilent Technologies, Inc, Allele Biotechnology and Pharmaceuticals Inc, Applied StemCell, ATUM (DNA 2.0), Beam Therapeutics, Bio-Rad Laboratories, Bluebird bio, Inc., Caribou Biosciences, Inc., CRISPR Therapeutics, Editas Medicine, EMD Millipore (Merck KGaA), GeneCopoeia, GenScript Corporation, Horizon Discovery Ltd, Integrated DNA Technologies Inc, Intellia Therapeutics, Origene Technologies, Precision Biosciences, Sangamo Therapeutics, Takara Bio Inc, Thermo Fisher Scientific
Growth Drivers:
  • Increased funding for genetic research in North America
  • Rising R&D expenditure and growth of biotechnology in Europe
  • Increasing demand for synthetic genes in Asia Pacific and North America
  • Technology advancements in gene editing in North America
Pitfalls & Challenges:
  • Stringent government regulations
  • Lack of public awareness in underdeveloped economies

Get more details on this report - Request Free Sample PDF
 

Surging demand for CRISPR/Cas9 technology will favour the gene editing market growth

The CRISPR/Cas9 segment will witness more than 15% growth rate during the forecast period. Rising demand for CRISPR/Cas9 in altering the genome of organisms to develop commercially feasible products will accelerate the market demand. Also, CRISPR technology is easy to use, simple, and inexpensive unlike the other gene editing techniques such as TALENs, thereby, increasing its adoption rate. Key market players such as Thermo Fisher Scientific, Takara Bio, Caribou Biosciences are focusing on R&D activities for adding innovations in the CRISPR/Cas9 technology that has raised preference in research processes.
 

Increasing application of cell line engineering will drive the overall market expansion

Global Gene Editing Market

Get more details on this report - Request Free Sample PDF
 

The cell line engineering segment size in the gene editing market was over USD 1.5 Billion in 2019. Cell-line engineering technology has wide applications in stem cell research, particularly for induced pluripotent stem cells (iPSCs) that helps in genetically modifying the stem cell resulting in rapid growth of iPSCs lines. Recent advances in gene editing techniques including CRISPR/Cas, TALENs and Zinc Finger Nucleases (ZFNs) have made cell engineering easy and cheaper, propelling its demand.
 

Rising focus on developing novel gene editing technologies

The biotech and pharma companies segment dominated around 46% gene editing market share in 2019 owing to increasing focus of biotech companies on developing advanced gene editing technologies. For instance, Bio-Rad Laboratories aims to create genome editing tools pipeline by launching several gene editing tools including digital droplet PCR (ddPCR). Technological advancements in gene editing enable market players to develop advanced technologies that are efficient enough in treatment of a specific genetic disease as compared to the conventional therapies.
 

Increasing adoption rate of gene editing techniques in the North American region

North America Gene Editing Market

Get more details on this report - Request Free Sample PDF
 

North America gene editing market accounted for over 37% revenue share in 2019. Rising prevalence of rare diseases in the U.S. and Canada has stimulated the demand for gene editing techniques that are used in developing drugs. As per the Rare Genomics Institute, 1 in 10 people suffer from rare disease across the U.S. Also, developed countries such as the U.S. has significant adoption rate of gene editing technologies such as CRISPR-Cas9, TALENs and ZFNs due to increase in research activities and affordability of high-end technologies.
 

Strategic initiatives undertaken by leading market players have helped them develop advanced product portfolio

Some of the leading players operating in the gene editing market include Thermo Fisher Scientific, Integrated DNA Technologies, Agilent Technologies, EMD Millipore (Merck KGAa), Takara Bio, Horizon Discovery, Origene Technologies, Sangamo Therapeutics, Caribou Biosciences. These companies are undertaking several organic and inorganic growth strategies to garner higher industry revenue.
 

Recent Gene Editing Industry Developments:

  • In May 2020, Caribou Science entered into commercial and clinical license agreement with MaxCyte. The agreement was aimed to gain exclusive rights to use MaxCyte’s flow electroporation technology as well as ExPERT platform. This is expected to advance Caribou’s gene-edited allogenic T cell therapy programs and expand their corporate relations in the market.
     
  • In June 2019, Allele Biotechnology and Alpine BioTherapeutics Corporation announced an agreement for developing induced pluripotent stem cells for treatment of retinal diseases. This strategy assisted the company in developing advanced product portfolio.
     

The gene editing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

Market, By Application

  • Cell line engineering
  • Animal genetic engineering
  • Plant genetic engineering
  • Others

Market, By Technology

  • CRISPR/Cas9
  • Zinc Finger Nucleases (ZFNs)
  • TALENs
  • Others

Market, By End-user

  • Biotech and pharma companies
  • Contract research organizations (CROs)
  • Research institutes

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Poland
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Frequently Asked Questions (FAQ) :

In 2019, the global market size for gene editing was worth USD 3.8 billion and may register 14.9% CAGR between 2020 and 2026.
CRISPR/Cas9 segment will observe 15% CAGR through 2026, as the technology is widely used for altering the genome of organisms to develop commercially feasible products.
North America held 37% of the industry share in 2019 and may exhibit commendable traction due to increasing prevalence of rare diseases in the U.S. and Canada.
The cell line engineering segment was worth USD 1.5 billion in 2019. The application segment will exhibit immense growth owing to rising cell engineering usage in stem cell research.
The biotech and pharma companies segment led the global industry with 46% share in 2019 and will depict appreciable growth, owing to rising focus of biotech firms to develop advanced gene editing technologies.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Sep 2020
  • Pages: 141
  • Tables: 103
  • Charts / Figures: 14
  • Companies covered: 22
  • Countries covered: 20

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X